Karuna Therapeutics Files for $52 Million Offering

Karuna Therapeutics filed the paperwork for a $52 Million offering on 11/18/19. The Boston, MA based company focuses on developing treatments for neurological disorders and currently has develop programs for schizophrenia, Alzheimer's and pain. Their stock trades on NASDAQ under the symbol “KRTX."